Well, me, too. Clearly the one-month no-dosing period was not enough to discern how long Anavex 3-71 is able to sustain positive therapeutic outcomes after it is no longer administered. At least for one month. But how much longer after that? That should be a new, separate study --- which Anavex itself may have already conducted.